Singapore‑Style Sickness: Indonesia’s Syrupy Scandal Gets a Feisty Make‑over
Imagine your favorite kid‑friendly cough syrup suddenly turns into a chemical nightmare—that’s exactly what sketched the headlines in Jakarta. Indonesian authorities have snuffed out the rights of two local pharmaceutical giants after uncovering that their “sweet‑treat” medicines were secretly harvesting industrial ingredients better suited for car engines than kids’ medicine cabinets.
Why the Shake‑up?
- Over 150 children, most under 5, have suffered acute kidney injury (AKI) linked to syrup crashes.
- Investigators found ethylene glycol and diethylene glycol—the very chemicals you’d rather find in car antifreeze than a throaty relief liquid.
- Both are toxic and can bolt your kidneys into a do‑not‑go‑anywhere zone.
License License—Gone
The Food and Drug Authority (BPOM) fired the bell on PT Yarindo Farmatama and PT Universal Pharmaceutical Industries, revoking their “oral liquid” production licences and promising a full‑blown criminal probe.
The “Glycerine” Grab‑back
These companies tried to cheat the system by swapping glycerine (the standard, safe solvent for cough syrups) with cheaper industrial grade stuff, and then kept the change a secret. The result? A toxic cocktail that knocked out the safety net that keeps babies from turning into a medical mystery.
Who’s Negotiating?
PT Yarindo Farmatama didn’t bark back to the reporters. A lawyer from PT Universal Pharmaceutical Industries stayed tight‑lipped, citing the investigation still on. For the general public, it’s just a no‑exit‑hazard situation.
Behind the Curtain: Supplies and Whispers
Indonesia’s health ministry says it mainly imports raw ingredients from China and India—so the alleged leakage may have come from “foreign” sources. One suspect solvent, propylene glycol, allegedly comes from Dow Chemical Thailand. Down that branch, the vendor kept a quiet “We’re not your customer” stance though they’ve supplied analysis data to BPOM.
The Bigger Picture
WHO is on board, because a similar pickle hit Gambia earlier this year where a local brand made syrup fatalities—70 children lost without a clear safety net.
Bottom Line: No Syrups, No Kids, No Problems
Indonesia’s jugular‑up in choking children has become a cautionary tale on how sneaky ingredient swaps can cripple health. It’s a stark reminder that a child’s sweet will, if under the wrong eyes, can’t protect them. Regulations have tightened, investigations continue, and the hope is for better safety tides to ban the dark side of medicine, lest the next batch of cough syrup become a “who’s-turned-into-a-wormhole” for the little ones.
